Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Spacek

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 28, 2019
Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national studyKamila Stranska, Karla Plevova, Hana Skuhrova Francova, et al.
Annals of Hematology|November 21, 2019
Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemiaGilles Salles, Emmanuel Bachy, Lukas Smolej, et al.
European Journal of Haematology|October 11, 2024
Real-World Evidence on Prognostic Value of MRD in Multiple Myeloma Using Flow CytometryLudmila Muronova, Ondrej Soucek, David Zihala, et al.
British Journal of Haematology|April 1, 2015
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patientsAnders Österborg, William G Wierda, Jiří Mayer, et al.
Cytometry. Part B, Clinical Cytometry|October 13, 2017
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation projectAndy C Rawstron, Karl-Anton Kreuzer, Asha Soosapilla, et al.
Haematologica|February 13, 2008
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disordersAndy C Rawstron, Alberto Orfao, Meral Beksac, et al.
Cancer Medicine|September 24, 2020
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US studyAntonio Cuneo, Anthony R Mato, Gian Matteo Rigolin, et al.
American Journal of Hematology|February 26, 2020
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study groupYair Herishanu, Adir Shaulov, Riva Fineman, et al.
Hemasphere|September 18, 2024
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLLThomas Chatzikonstantinou, Lydia Scarfò, Eva Minga, et al.
Eclinicalmedicine|November 30, 2023
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONYThomas Chatzikonstantinou, Lydia Scarfò, Georgios Karakatsoulis, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 28, 2019
Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national studyKamila Stranska, Karla Plevova, Hana Skuhrova Francova, et al.
Annals of Hematology|November 21, 2019
Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemiaGilles Salles, Emmanuel Bachy, Lukas Smolej, et al.
European Journal of Haematology|October 11, 2024
Real-World Evidence on Prognostic Value of MRD in Multiple Myeloma Using Flow CytometryLudmila Muronova, Ondrej Soucek, David Zihala, et al.
British Journal of Haematology|April 1, 2015
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patientsAnders Österborg, William G Wierda, Jiří Mayer, et al.
Cytometry. Part B, Clinical Cytometry|October 13, 2017
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation projectAndy C Rawstron, Karl-Anton Kreuzer, Asha Soosapilla, et al.
Haematologica|February 13, 2008
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disordersAndy C Rawstron, Alberto Orfao, Meral Beksac, et al.
Cancer Medicine|September 24, 2020
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US studyAntonio Cuneo, Anthony R Mato, Gian Matteo Rigolin, et al.
American Journal of Hematology|February 26, 2020
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study groupYair Herishanu, Adir Shaulov, Riva Fineman, et al.
Hemasphere|September 18, 2024
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLLThomas Chatzikonstantinou, Lydia Scarfò, Eva Minga, et al.
Eclinicalmedicine|November 30, 2023
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONYThomas Chatzikonstantinou, Lydia Scarfò, Georgios Karakatsoulis, et al.
Pageof 2